Prev Close | 10.79 |
Day Low/High | 10.32 / 11.04 |
52 Wk Low/High | 4.00 / 15.83 |
Prev Close | 10.79 |
Day Low/High | 10.32 / 11.04 |
52 Wk Low/High | 4.00 / 15.83 |
Exchange | NASDAQ |
Shares Outstanding | 356.19B |
Market Cap | 3.84B |
P/E Ratio | 5.66 |
Div & Yield | N.A. (N.A) |
Real Money tapped an industry expert to discuss the outlook for buying and selling of cannabis companies.
If the Democrats sweep, you have perhaps the best single stock in the market.
Altria has future growth potential, over 50 years of dividend increases and a high yield exceeding 8%.
It continues to be a very good market for aggressive traders that focus on stock-picking and sectors.
This six-pack from investment specialists includes a REIT and a software provider specializing in the industry.
These companies initially seemed to believe that regulators and law enforcement would drive out the illicit market dealers. That hasn't happened.
Here are three names that should drag on as other financially strapped names risk going up in smoke.
Last week's "Trade of the Week" -- a basket of speculative cannabis stocks -- was intended, as I wrote, through the end of the year. In looking at the buy levels, it was a very successful idea -- with three of the stocks rising by more than 20% as ...
Some market highlights today (in my book): * Kraft Heinz sneaking back to the old highs. *Cronos Group and Canopy Growth Corp (a helluva trade off of the morning lows) are cannabis leadership. * Cannabis spec basket still ++. * The iShares Barclays ...
Cannabis stocks are continuing to get their groove back this morning - with good gains in , , , and .
Here is your Marijuana Moment. Last week, my Trade of the Week (and a half!) was a basket of cannabis stocks -- and I moved to large sized in all of them during the week (Note: The stocks started to roll higher on Friday): My package includes  ($7.0...
* My package includes ($7.00), ($5.69), ($5.45), ($2.25) and ($8.15) * It is likely that the maximum tax selling pressure is now virtually over * While technically "The Trade of the Week" - this is my favorite group to benefit from the "January Effe...
* In the hope for a "January Effect" after tax loss selling in December I added to ($7.82), ($6.70), ($5.90), ($5.29) and ($2.19) today.
Morningstar Magazine offers insight into future growth potential for cannabis industry and stocks.
A look at what the weekly charts of three big cannabis names are saying.
* My revised levels I don't want there to be any ambiguity about the size of my positions or about my buy and short levels as I strive for as much transparency as possible. "When the time comes to buy, you won't want to." - Walter Deemer "When the t...
I am adding names to my basket of cannabis stocks - including ($8.80), and a number of very small speculative stocks that are too racy to name.
Shares of the cannabis company are likely to drift lower in the weeks ahead.
Let's look at the chart of CRON.
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
It all comes down to matching my time frame.
Here's how to play OGI stock right now.
Two of them are brand new.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.